These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 20332752)
1. Imatinib: high dose versus standard dose. Jabbour E Clin Adv Hematol Oncol; 2009 Dec; 7(12):812-4. PubMed ID: 20332752 [No Abstract] [Full Text] [Related]
2. Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser. Druker BJ J Hematother Stem Cell Res; 2001 Dec; 10(6):721-4. PubMed ID: 11798498 [No Abstract] [Full Text] [Related]
3. Position paper on imatinib mesylate in chronic myeloid leukaemia. O'Brien SG; Rule SA Br J Haematol; 2002 Oct; 119(1):268-72. PubMed ID: 12358935 [No Abstract] [Full Text] [Related]
4. New agent overcomes resistance to imatinib. Ahmad K Lancet Oncol; 2005 Mar; 6(3):137. PubMed ID: 15759363 [No Abstract] [Full Text] [Related]
5. Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia. Milojkovic D; Short K; Salisbury JR; Creamer D; du Vivier AW; Mufti GJ Leukemia; 2003 Jul; 17(7):1414-6. PubMed ID: 12835733 [No Abstract] [Full Text] [Related]
6. Response to the case report by Mattar: Generic Imatinib (Imatib, Cipla) in a patient with chronic myeloid leukemia in chronic phase. Gogtay J; Chahchad S; Jadhav S; Purandare S Int J Hematol; 2010 Dec; 92(5):772-3. PubMed ID: 21082296 [No Abstract] [Full Text] [Related]
7. Imatinib mesylate: a new pill for chronic myelogenous leukemia. Parmar KK; King RS Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324 [No Abstract] [Full Text] [Related]
8. Gold standard or wrong standard? Oldham R; Dillman R Cancer Biother Radiopharm; 2004 Jun; 19(3):271-2. PubMed ID: 15285873 [No Abstract] [Full Text] [Related]
9. Efficacy of surgery and imatinib mesylate in the treatment of advanced gastrointestinal stromal tumor: a systematic review. Cirocchi R; Farinella E; La Mura F; Cavaliere D; Avenia N; Verdecchia GM; Giustozzi G; Noya G; Sciannameo F Tumori; 2010; 96(3):392-9. PubMed ID: 20845798 [TBL] [Abstract][Full Text] [Related]
10. Sunitinib for imatinib-resistant GIST. Joensuu H Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443 [No Abstract] [Full Text] [Related]
11. Lack of response to imatinib mesylate as second-line therapy in a patient with c-kit positive metastatic soft tissue leiomyosarcoma. Silvestris N; Parra HS; Angelini F; Di Cosimo S; D'Aprile M; Santoro A Tumori; 2005; 91(1):103. PubMed ID: 15850018 [No Abstract] [Full Text] [Related]
12. Imatinib mesylate. Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724 [No Abstract] [Full Text] [Related]